| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $100K | -11.4% |
| SG&A Expense | $61K | -38.3% |
| Income Tax | $0 | — |
| Net Income | -$364K | +12.3% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Total Assets | $466K | -3.0% |
| Current Liabilities | $124K | +177.5% |
| Stockholders' Equity | $342K | -21.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$223K | +40.7% |
| Investing Cash Flow | -$58K | +1.9% |
| Financing Cash Flow | $256K | -40.5% |